Skip to main content Accessibility help
×
Home

Identifying newly acquired cases of hepatitis C using surveillance: a literature review

  • R. SACKS-DAVIS (a1) (a2), C. VAN GEMERT (a1) (a3), I. BERGERI (a1), M. STOOVE (a1) (a2) and M. HELLARD (a1) (a2) (a4)...

Summary

Surveillance of newly acquired hepatitis C virus (HCV) infection is crucial for understanding the epidemiology of HCV and informing public health practice. However, monitoring such infections via surveillance systems is challenging because they are commonly asymptomatic. A literature review was conducted to identify methodologies used by HCV surveillance systems to identify newly acquired infections; relevant surveillance systems in 15 countries were identified. Surveillance systems used three main strategies to identify newly acquired infections: (1) asking physicians to classify cases; (2) identifying symptomatic cases or cases with elevated alanine aminotransferases; and (3) identifying cases with documented evidence of anti-HCV antibody seroconversion within a specific time-frame. Case-ascertainment methods varied with greater completeness of data in enhanced compared to passive surveillance systems. Automated systems that extract and link testing data from multiple laboratory and clinic databases may provide an opportunity for collecting testing histories for individuals that is less resource intensive than enhanced surveillance.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Identifying newly acquired cases of hepatitis C using surveillance: a literature review
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Identifying newly acquired cases of hepatitis C using surveillance: a literature review
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Identifying newly acquired cases of hepatitis C using surveillance: a literature review
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Ms. R. Sacks-Davis, Centre for Population Health, 85 Commercial Rd, Melbourne, Victoria, 3004, Australia. (Email: rachelsd@burnet.edu.au)

References

Hide All
World Health Organization. Viral cancers (http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html). Geneva: World Health Organization. Accessed 5 January 2009.
Shepard, CW, Finelli, L, Alter, MJ. Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 2005; 5: 558567.
Galea, S, Vlahov, D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Reports 2002; 117: S135 145.
van de Laar, TJ, et al. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010; 24: 17991812.
Gamage, DG, et al. Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infectious Diseases 2011; 11: 39.
World Health Organization. Sixty-third World Health Assembly: agenda item 11.12 (http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R18-en.pdf), 2010. Accessed April 2011.
Zickmund, S, et al. ‘They treated me like a leper’. Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine 2003; 18: 835844.
Edlin, BR. Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room. International Journal of Drug Policy 2004; 15: 8191.
Miller, N, et al. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Academic Medicine: Journal of the Association of American Medical Colleges 2001; 76: 410418.
Stoove, M, Gifford, S, Dore, G. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence 2005; 77: 8186.
Applied Economics. Economic evaluation of hepatitis C in Australia. Sydney: Australian Government Department of Health and Ageing, 2005.
Maheshwari, A, Ray, S, Thuluvath, PJ. Acute hepatitis C. Lancet 2008; 372: 321332.
Seeff, L. Natural history of chronic hepatitis C. Hepatology 2002; 36: S3546.
Buehler, J. Surveillance. In: Rothman, KJ, Greenland, S, eds. Modern Epidemiology, 2nd edn. Philedelphia, PA: Lippincott-Raven, 1998.
Centers for Disease Control and Prevention. Guidelines for viral hepatitis surveillance and case management. Atlanta, GA, 2005.
Kamal, SM. Acute hepatitis C: prospects and challenges. World Journal of Gastroenterology 2007; 13: 64556457.
Kamal, SM, et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology 2006; 130: 632638.
Jaeckel, E, et al. Treatment of acute hepatitis C with interferon alfa-2b. New England Journal of Medicine 2001; 345: 14521457.
Dore, GJ, et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 2010; 138: 123135.e122.
Martin, NK, et al. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology 2012; 55: 4957.
Martin, NK, et al. Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users. PLoS One 2011; 6: e22309.
Martin, NK, Vickerman, P, Hickman, M. Mathematical modelling of hepatitis C treatment for injecting drug users. Journal of Theoretical Biology 2011; 274: 5866.
Martin, NK, et al. Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of Hepatology 2011; 54: 11371144.
Vickerman, P, Martin, N, Hickman, M. Can hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere. Drug and Alcohol Dependence 2011; 113: 8385; discussion 8687.
World Health Organization. Protocol for the assessment of national communicable disease surveillance and response systems. World Health Organisation Department of Communicable Disease Surveillance and Response, 2001.
Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. Morbidity and Mortality Weekly Report 2001; 50.
Overhage, JM, Grannis, S, McDonald, CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. American Journal of Public Health 2008; 98: 344350.
European Centre for Disease Prevention and Control. Surveillance and prevention of hepatitis B and C in Europe. Stockholm: ECDC, 2010.
Talaat, M, et al. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001–04. Eastern Mediterranean Health Journal 2010; 16: 134140.
Selvey, LA, et al. Investigation of notifications of hepatitis C in 1994: the experience of three health departments. Australian and New Zealand Journal of Public Health 1996; 20: 525529.
Robotin, MC, et al. Surveillance for newly acquired hepatitis C in Australia [see comment]. Journal of Gastroenterology and Hepatology 2004; 19: 283288.
Guy, R, et al. Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications. Communicable Diseases Intelligence 2008; 32: 250256.
Staff, MP, et al. Public health surveillance of hepatitis C: can it identify incident cases? Australian and New Zealand Journal of Public Health 2000; 24: 198200.
Olmsted, RN. Is the recent increase in the reported cases of hepatitis C/NANB a real increase? American Journal of Infection Control 1996; 24: 415416.
Sokol, TM, et al. Hepatitis C infection in Louisiana. Journal of the Louisiana State Medical Society 2005; 157: 98102.
Ruf, M, et al. Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. Eurosurveillance 2008; 13: pii=19042.
Finelli, L, et al. National surveillance of dialysis-associated diseases in the United States, 2002. Seminars in Dialysis 2005; 18: 5261.
Tokars, JI, et al. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO Journal 1998; 44: 98107.
Tokars, JI, et al. National surveillance of dialysis-associated diseases in the United States, 1997. Seminars in Dialysis 2000; 13: 7585.
elSaadany, S, Gully, P, Giulivi, A. Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993–1995. Canadian Journal of Public Health 2002; 93: 435438.
Wu, H-X, et al. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004. Scandinavian Journal of Infectious Diseases 2006; 38: 482489.
Zou, S, et al. Enhanced surveillance of acute hepatitis B and C in four health regions in Canada, 1998 to 1999. Canadian Journal of Infectious Diseases 2001; 12: 357363.
Alter, M, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Journal of the American Medical Association 1990; 264: 22312235.
Alter, M, et al. The natural history of community-acquired hepatitis C in the United States. New England Journal of Medicine 1992; 327: 18991905.
Spada, E, et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Digestive and Liver Disease 2001; 33: 778784.
Mele, A, et al. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. European Journal of Epidemiology 1986; 2: 300304.
Mele, A, et al. Heterosexual transmission of hepatitis C in Italy. Journal of Medical Virology 1999; 57: 111113.
Tosti, ME, et al. Incidence of parenterally transmitted acute viral hepatitis among healthcare workers in Italy. Infection Control and Hospital Epidemiology 2007; 28: 629632.
Stroffolini, T, et al. Incidence of non-A, non-B and HCV positive hepatitis in healthcare workers in Italy. Journal of Hospital Infection 1996; 33: 131137.
Bianco, E, et al. Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An update. Digestive and Liver Disease 2003; 35: 404408.
Centers for Disease Control and Prevention. Evaluation of acute hepatitis C infection surveillance – United States, 2008. Morbidity and Mortality Weekly Report 2010; 59: 14071410.
Daniels, D, et al. Surveillance for acute viral hepatitis – United States, 2007. Morbidity and Mortality Weekly Report Surveillance Summaries 2009; 58: 127.
Gidding, HF, et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997–2006. Journal of Gastroenterology and Hepatology 2009; 24: 16481654.
Memish, ZA, Knawy, BA, El-Saed, A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. International Journal of Infectious Diseases 2010; 14: e115120.
Brant, LJ, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiology and Infection 2007; 135: 417426.
Tweed, E, et al. Hepatitis C testing in sexual health services in England, 2002–7: results from sentinel surveillance. Sexually Transmitted Infections 2010; 86: 126130.
Strauss, B, Bigham, M. Hepatitis C surveillance – are we doing enough? British Columbia, 2001. Canada Communicable Disease Report 2002; 28: 149156.
Kuo, M, et al. Newly acquired hepatitis C virus infection in British Columbia, 1992–2005. Canadian Digestive Diseases Week (CDDW), the annual scientific conference of the Canadian Association of Gastroenterology (CAG). Montreal: The Canadian Association of Gastroenterology and The Canadian Association for the Study of the Liver, 2008.
Public Health Agency of Canada. Enhanced surveillance of risk behaviours among people who inject drugs. Phase I Report, August 2006. Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006.
Fleming, DT, et al. Surveillance programs for chronic viral hepatitis in three health departments. Public Health Reports 2006; 121: 2335.
Fong, F. An epidemiologic summary of the hepatitis C epidemic in Minnesota. Minnesota Medicine 2003; 86: 4651.
Gasiorowicz, M, et al. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin. Wisconsin Medical Journal 2006; 105: 3439.
Gungabissoon, U, Balogun, MA, Ramsay, ME. Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004. Epidemiology and Infection 2007; 135: 541548.
O'Meara, M, Barry, J, Mullen, L. Epidemiology of hepatitis C infection, ERHA/HSE Eastern region. Irish Medical Journal 2007; 100: 365366.
Shaw, L, et al. Establishment of a database of diagnosed HCV-infected persons in Scotland. Communicable Disease and Public Health 2003; 6: 305310.
Chaves, S, Widdowson, MA, Bosman, A. Surveillance of HCV infection in the Netherlands [see comment]. Eurosurveillance 2003; 8: 108113.
Duberg, A, et al. The epidemiology of hepatitis C virus infection in Sweden. Eurosurveillance 2008; 13.
Lim, M, et al. Hepatitis C sentinel surveillance in Victoria. In: Australasian Viral Hepatitis Conference. Brisbane, 2008.
National Centre in HIV Epidemiology and Clinical Research. Australian needle and syringe program survey national data report 2004–2008. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 2009.
Backus, LI, et al. Clinical case registries: simultaneous local and national disease registries for population quality management. Journal of the American Medical Informatics Association 2009; 16: 775783.
Costa, ZB, et al. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infectious Diseases 2009; 9: 116.
Craine, N, et al. Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiology and Infection 2009; 137: 12551265.
Khattab, MA, et al. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000–2008. American Journal of Infection Control 2010; 38: 640641.
Klevens, RM, et al. Population-based surveillance for hepatitis C virus, United States, 2006–2007. Emerging Infectious Diseases 2009; 15: 14991502.
McQuillian, GM, et al. Viral hepatitis. National Center for Health Statistics data brief 2010: 18.
Madani, TA. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009; 103: 132136.
Platt, L, et al. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation. European Journal of Public Health 2009; 19: 428433.
Sofair, AN, et al. Use of fax-back surveillance to determine epidemiologic and clinical characteristics of patients diagnosed with hepatitis C in Waterbury, Connecticut. Connecticut Medicine 2009; 73: 593595.
Ximenes, RAdA, et al. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cadernos de saúde pública 2010; 26: 16931704.
World Health Organization. WHO recommended surveillance standards: second edition. Geneva: World Health Organisation Department of Communicable Disease Surveillance and Response, 1999 October.
Commission of the European Communities. Commission decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the community network under Decision No. 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Communities 2002; L86: 4462.
Haley, RW, Fischer, RP. The tattooing paradox – are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? 129th Annual Meeting of the American Public Health Association. Atlanta, Georgia: American Medical Association, 2001, 1095.
Pradat, P, et al. Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology 2002; 36: 973977.
Tobin, S. Hepatitis C: enhancing routine surveillance in Victoria. Victorian Infectious Diseases Bulletin 2001; 4: 1719.
Seeff, LB. The history of the ‘natural history’ of hepatitis C (1968–2009). Liver International 2009; 29: 8999.
Aitken, CK, et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008; 48: 17461752.
Grebely, J, et al. Hepatitis C virus reinfection in injection drug users [see comment]. Hepatology 2006; 44: 11391145.
Mehta, SH, et al. Protection against persistence of hepatitis C. Lancet 2002; 359: 14781483.
Micallef, JM, et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. Journal of Viral Hepatitis 2007; 14: 413418.
Osburn, WO, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010; 138: 315324.
Page, K, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. Journal of Infectious Diseases 2009; 200: 12161226.
Pham, ST, et al. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 2010; 52: 15641572.
van de Laar, TJW, et al. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam [see comment]. Journal of Hepatology 2009; 51: 667674.
Vickerman, P, et al. The more you look the more you find – effects of hepatitis C virus testing interval on re-infection incidence and clearance: implications for future vaccine study design. Journal of Infectious Diseases 205: 13421350.
Hope, VD, et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Journal of Viral Hepatitis 2011; 18: 262270.
Page-Shafer, K, et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. Journal of Clinical Microbiology 2008; 46: 499506.
Turner, KME, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 2011; 106: 19781988.
European Monitoring Centre for Drugs and Drug Addiction. Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users. EMCDDA Manuals, Lisbon, 2010.
European Association for the Study of Liver Disease. International Consensus Conference on Hepatitis C Paris, 26–28 February 1999: Consensus statement. Journal of Hepatology 1999; 30: 956961.
European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Stockholm: ECDC, 2010.
Hatzakis, A, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. Journal of Viral Hepatitis 2011; 18: 116.
Calvaruso, V, Craxì, A. 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines. Liver International 2012; 32: 28.
Chary, A, Holodniy, M. Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials. Reviews on Recent Clinical Trials 2010.
Gane, E. Future hepatitis C virus treatment: interferon-sparing combinations. Liver International 2011; 31: 6267.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed